NUREXONE BIOLOGIC INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.469 EUR | +4.22% |
|
-4.74% | +158.48% |
| 05-29 | NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
Evolution of the average Target Price on NurExone Biologic Inc.
Price target over the last 5 years
History of analyst recommendation changes
4.ABMEzsoQe18ZrdSRSqb0wtIKSFhDNZi2_tGM_gaL7V4.aHgypZ9XFW1aypmjIZfFs_9IHG8retX6h7P1xmvUsghTIlWI_UcjHGyegQ~a1c3cb9b0d517b244748e8e132f2ae68
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5283
USD
Average target price
2.918
USD
Spread / Average Target
+452.37%
High Price Target
2.918
USD
Spread / Highest target
+452.37%
Low Price Target
2.918
USD
Spread / Lowest Target
+452.37%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- NRX Stock
- J90 Stock
- Consensus NurExone Biologic Inc.
